Use of ATC to describe duplicate medications in primary care prescriptions
- 157 Downloads
We aimed to demonstrate the suitability of the Anatomical Therapeutic Chemical Classification (ATC) to describe duplicate drugs and duplicate drug classes in prescription data and describe the pattern of duplicates from public and private primary care clinics of Kuala Lumpur, Malaysia.
We analyzed prescription data year 2005 from all 14 public clinics in Kuala Lumpur with 12,157 prescriptions, and a sample of 188 private clinics with 25,612 prescriptions. As ATC Level 5 code represents the molecule and Level 4 represents the pharmacological subgroup, we used repetitions of codes in the same prescription to describe duplicate drugs or duplicate drug classes and compared them between the public and private clinics.
At Level 4 ATC, prescriptions with duplicates drug classes were 1.46% of all prescriptions in private and 0.04% in public clinics. At Level 5 ATC, prescriptions with duplicate drugs were 1.81% for private and 0.95% for public clinics. In private clinics at Level 5, 73.3% of prescriptions with duplicates involved systemic combination drugs; at Level 4, 40.3% involved systemic combination drugs. In the public sector at Level 5, 95.7% of prescriptions with duplicates involved topical products.
Repetitions of the same ATC codes were mostly useful to describe duplicate medications; however, we recommend avoid using ATC codes for tropical products for this purpose due to ambiguity. Combination products were often involved in duplicate prescribing; redesign of these products might improve prescribing quality. Duplicates occurred more often in private clinics than public clinics in Malaysia
KeywordsDuplicate prescribing Duplicate drugs ATC Combination drugs
We thank the Director General of Health for permission to publish findings of this study and thank all doctors and pharmacists who participated in the NMUS.
Conflict of interest
This research was conducted by data from National Medicines Use Survey (NMUS). NMUS was sponsored by a grant from Ministry of Health (MRG Grant Number 00311). The authors of this paper work in the Ministry of Health, Malaysia. Pharmaceutical Services Division manages pharmacists and the drug formulary of Ministry of Health.
- 2.Holloway K, Green T (eds) (2003) Drugs and Therapeutics Committee: A practical guide, World Health Organization, pp 81–82Google Scholar
- 14.WHO Collaborating Centre for Drug Statistics Methodology (2006) Guidelines for ATC classification and DDD assignment 2007, Oslo.Google Scholar
- 15.De Smet PAGM (1993) New Applications of the ATC/DDD methodology in the Netherlands Part 1. ATC/DDD principles and computerized medication surveillance. Int Pharm J 7:196–199Google Scholar
- 16.Klaukka T (2009) The Finnish database on drug utilization.Norwegian. J Epidemiol 11:19–22Google Scholar
- 17.Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735PubMedCrossRefGoogle Scholar
- 18.Furu K (2009) Establishment of the nationwide Norwegian Prescription Database (NorPD)–new opportunities for research in pharmacoepidemiology in Norway. Nor Epidemiol 18:129–136Google Scholar
- 19.Sameerah SAR, Sarojini S. (ed) (2007) Malaysian Statistics on Medicine 2005. Ministry of Health Malaysia, Kuala Lumpur, pp xi- xviGoogle Scholar
- 20.Sawyer D, Aziz KJ, Backinger CL et al. (1996) Do it by Design: an introduction to human factors in medical devices, US Department of Health and Human Services, Food and Drug Administration http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm095061.pdf